Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Tepeköylü

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|April 22, 2014
Shock wave application to cell culturesJohannes Holfeld, Can Tepeköylü, Radoslaw Kozaryn, et al.
Inflammation|August 17, 2013
Shockwave therapy differentially stimulates endothelial cells: implications on the control of inflammation via toll-Like receptor 3Johannes Holfeld, Can Tepeköylü, Radoslaw Kozaryn, et al.
Microvascular Research|June 28, 2015
Combined peri-ischemic administration of Bβ15-42 in treating ischemia reperfusion injury of the mouse kidneyAnja Urbschat, Katrin Rupprecht, Kai Zacharowski, et al.
Journal of Tissue Engineering and Regenerative Medicine|October 1, 2016
Shock wave treatment after hindlimb ischaemia results in increased perfusion and M2 macrophage presenceCan Tepeköylü, Daniela Lobenwein, Anja Urbschat, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Shockwaves prevent from heart failure after acute myocardial ischaemia via RNA/protein complexesCan Tepeköylü, Uwe Primessnig, Leo Pölzl, et al.
Plos One|August 6, 2014
Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylationJohannes Holfeld, Can Tepeköylü, Stefan Blunder, et al.
Journal of the American Heart Association|October 29, 2015
Shock Wave Treatment Protects From Neuronal Degeneration via a Toll-Like Receptor 3 Dependent Mechanism: Implications of a First-Ever Causal Treatment for Ischemic Spinal Cord InjuryDaniela Lobenwein, Can Tepeköylü, Radoslaw Kozaryn, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 12, 2013
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesisCan Tepeköylü, Feng-Sheng Wang, Radoslaw Kozaryn, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 21, 2014
Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart diseaseJohannes Holfeld, Daniel Zimpfer, Karin Albrecht-Schgoer, et al.
Cardiovascular Research|December 18, 2015
Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscleJohannes Holfeld, Can Tepeköylü, Christin Reissig, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|April 22, 2014
Shock wave application to cell culturesJohannes Holfeld, Can Tepeköylü, Radoslaw Kozaryn, et al.
Inflammation|August 17, 2013
Shockwave therapy differentially stimulates endothelial cells: implications on the control of inflammation via toll-Like receptor 3Johannes Holfeld, Can Tepeköylü, Radoslaw Kozaryn, et al.
Microvascular Research|June 28, 2015
Combined peri-ischemic administration of Bβ15-42 in treating ischemia reperfusion injury of the mouse kidneyAnja Urbschat, Katrin Rupprecht, Kai Zacharowski, et al.
Journal of Tissue Engineering and Regenerative Medicine|October 1, 2016
Shock wave treatment after hindlimb ischaemia results in increased perfusion and M2 macrophage presenceCan Tepeköylü, Daniela Lobenwein, Anja Urbschat, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Shockwaves prevent from heart failure after acute myocardial ischaemia via RNA/protein complexesCan Tepeköylü, Uwe Primessnig, Leo Pölzl, et al.
Plos One|August 6, 2014
Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylationJohannes Holfeld, Can Tepeköylü, Stefan Blunder, et al.
Journal of the American Heart Association|October 29, 2015
Shock Wave Treatment Protects From Neuronal Degeneration via a Toll-Like Receptor 3 Dependent Mechanism: Implications of a First-Ever Causal Treatment for Ischemic Spinal Cord InjuryDaniela Lobenwein, Can Tepeköylü, Radoslaw Kozaryn, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 12, 2013
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesisCan Tepeköylü, Feng-Sheng Wang, Radoslaw Kozaryn, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 21, 2014
Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart diseaseJohannes Holfeld, Daniel Zimpfer, Karin Albrecht-Schgoer, et al.
Cardiovascular Research|December 18, 2015
Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscleJohannes Holfeld, Can Tepeköylü, Christin Reissig, et al.
Pageof 2